Roivant Sciences (STU:87S) Total Stockholders Equity : €4,955.9 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Roivant Sciences Total Stockholders Equity?

Roivant Sciences's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €4,955.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Roivant Sciences's Book Value per Share for the quarter that ended in Dec. 2024 was €6.89. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Roivant Sciences's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.02.

Roivant Sciences Total Stockholders Equity Historical Data

The historical data trend for Roivant Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roivant Sciences Total Stockholders Equity Chart

Roivant Sciences Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

1,510.14

1,504.51

1,081.35

5,491.10

Roivant Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Stockholders Equity	Get a 7-Day Free Trial														5,584.31	5,491.10	5,049.40	4,642.81	4,955.95

Roivant Sciences (STU:87S) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Roivant Sciences's Book Value per Share for the quarter that ended in Dec. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(4955.946	-	0)	/	719.632
	=	6.89

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Roivant Sciences's Debt-to-Equity for the quarter that ended in Dec. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(9.392	+	86.407)	/	4955.946
	=	0.02

Roivant Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Roivant Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Roivant Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (STU:87S) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ROIV:USA

Address

50 Broadway, 7th Floor, London, GBR, SW1H 0BD

Website

https://www.roivant.com

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Headlines

No Headlines